The dream of eliminating organ donor waiting lists is inching closer to reality with the advent of genetically modified pig organs for human transplantation. This breakthrough has enormous potential to address the severe shortage of human donor organs, a crisis that claims countless lives every year.
The current system relies on the selfless act of deceased organ donation and is inherently inadequate to meet the ever-increasing demand. Thousands of people die each year while waiting for life-saving transplants. Pig organs have similar size and anatomy to human organs, making them an attractive alternative.
However, a major obstacle is that our immune system has a natural tendency to reject foreign tissue. Scientists are tackling this challenge through genetic engineering. By carefully removing genes that cause rejection and introducing genes that are compatible with humans, researchers are creating pigs whose organs are less susceptible to attack by the human body.
Recently, the first successful pig-to-human kidney transplant marked a historic milestone. Although long-term effects are still being studied, the feasibility of this approach has been demonstrated. With further research and refinement, pig-to-human transplants could revolutionize organ donation.
The number of lives saved could be staggering. In the United States alone, more than 100,000 people are currently waiting for an organ transplant, and an average of 22 people die each day. A steady supply of genetically engineered pig organs could significantly reduce this number and provide hope to countless patients looking forward to a second chance.
Ethical considerations regarding animal welfare and the potential for transmission of swine viruses remain, but ongoing research is addressing these concerns. The potential benefits for human health are undeniable.Pig-to-human transplant offers glimmer of hope for a future free from the heartbreak of waiting in vain for life-saving organs
guest:
Dr. Martin Wijkström He is an associate professor of surgery and director of the islet cell transplant program at the University of Pittsburgh School of Medicine. His expertise is in xenotransplantation, primarily pancreatic islet and kidney models using genetically modified pig cells and organs.
“The Source” is a live call-in show that airs Monday through Thursday from 12:00 PM to 1:00 PM. Leave a message before the show at (210) 615-8982. During the live show, call 833-877-8255 or email [email protected].
*This interview will be recorded on Monday, April 1, 2024.
